Novartis hands over experimental TB drugs in antibiotic pullback
August 20, 2014 at 08:54 AM EDT
Novartis has signed a licensing deal to hand over its experimental tuberculosis (TB) drugs to the Global Alliance for TB Drug Development, joining a growing Big Pharma retreat from antibiotics
